Cargando…

1586. In Vitro Activity of Rifampin, Rifabutin, Rifapentine, and Rifaximin Against Biofilms Formed by Staphylococci Isolated from Prosthetic Joint Infection

BACKGROUND: Prosthetic joint infections (PJIs) are serious complications after total joint arthroplasty. Staphylococcus aureus and Staphylococcus epidermidis, which are proficient biofilm-formers, account for ~60% of PJI cases. Therapy often includes rifampin because of its anti-biofilm activity; th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albano, Mariana, Karau, Melissa J, Osmon, Douglas R, Oravec, Caitlin P, Abdel, Matthew P, Patel, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810379/ http://dx.doi.org/10.1093/ofid/ofz360.1450

Ejemplares similares

In Vitro Activity of Rifampin, Rifabutin, and Rifapentine against Enterococci and Streptococci from Periprosthetic Joint Infection
por: Albano, Mariana, et al.
Publicado: (2021)

Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients
por: Chang, Ji Young, et al.
Publicado: (2017)

Ex Vivo Human Placental Transfer of Rifampin and Rifabutin
por: Magee, Kevin P., et al.
Publicado: (1996)

Successful Anticoagulation With Warfarin After Switching From Rifampin to Rifabutin
por: Alnewais, Marwah E., et al.
Publicado: (2023)

Clinical Characteristics and Outcomes of Prosthetic Joint Infection Caused by Small Colony Variant Staphylococci
por: Tande, Aaron J., et al.
Publicado: (2014)

Assessment of vocation of rifabutin and rifapentine in replace of rifampcin in drug resistance leprosy patients: a molecular simulation study
por: Mohanty, Partha Sarathi, et al.
Publicado: (2017)

Activities of Rifampin, Rifapentine and Clarithromycin Alone and in Combination against Mycobacterium ulcerans Disease in Mice
por: Almeida, Deepak, et al.
Publicado: (2011)

rpoB Mutations are Associated with Variable Levels of Rifampin and Rifabutin Resistance in Mycobacterium tuberculosis
por: Li, Ma-Chao, et al.
Publicado: (2022)

691 Rifampin in the Treatment of Staphylococcal Prosthetic Joint Infections
por: Parsaei, Shadi, et al.
Publicado: (2014)

A Case Series of Rifabutin Use in Staphylococcal Prosthetic Infections
por: Monk, Miranda, et al.
Publicado: (2022)

Using dynamic oral dosing of rifapentine and rifabutin to simulate exposure profiles of long-acting formulations in a mouse model of tuberculosis preventive therapy
por: Chang, Yong S., et al.
Publicado: (2023)

Using Dynamic Oral Dosing of Rifapentine and Rifabutin to Simulate Exposure Profiles of Long-Acting Formulations in a Mouse Model of Tuberculosis Preventive Therapy
por: Chang, Yong S., et al.
Publicado: (2023)

691. Activity of TNP-2092 Against Biofilms Formed by Prosthetic Joint Infection-Associated Staphylococci
por: Fisher, Cody, et al.
Publicado: (2019)

Forbidden lectures in Yucatan, 1586
por: RAMOS DÍAZ, MARTÍN
Publicado: (2003)

Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy
por: Lenz, Shannon M., et al.
Publicado: (2020)

The early history of cuba 1492- 1586 /
por: Wright, Irene Aloha, 1879-1972
Publicado: (1916)

793. Rifabutin Use in Staphylococcal Prosthetic Material Infections: A Case Series
por: Monk, Miranda, et al.
Publicado: (2021)

Comparison of Rifabutin-Based Versus Rifampin-Based Regimens for the Treatment of Mycobacterium avium Complex: A meta-Analysis Study
por: Hajikhani, Bahareh, et al.
Publicado: (2021)

Rifabutin Use in Staphylococcus Biofilm Infections: A Case Series
por: Doub, James B., et al.
Publicado: (2020)

Correlation of rpoB Mutations with Minimal Inhibitory Concentration of Rifampin and Rifabutin in Mycobacterium tuberculosis in an HIV/AIDS Endemic Setting, South Africa
por: Rukasha, Ivy, et al.
Publicado: (2016)

Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial
por: Wallis, Robert S., et al.
Publicado: (2018)

In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae
por: Lee, Bosul, et al.
Publicado: (2021)

Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial
por: Karlsen, Øystein Espeland, et al.
Publicado: (2020)

Differential Impact of the rpoB Mutant on Rifampin and Rifabutin Resistance Signatures of Mycobacterium tuberculosis Is Revealed Using a Whole-Genome Sequencing Assay
por: Yu, Ming-Chih, et al.
Publicado: (2022)

Anti-biofilm activity of antibiotic-loaded Hylomate®
por: Albano, Mariana, et al.
Publicado: (2021)

Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine
por: McClintock, Adelaide H., et al.
Publicado: (2017)

Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir
por: Moultrie, Harry, et al.
Publicado: (2015)

Rifampin for Staphylococcal Prosthetic Joint Infection: Do We Still Need a Randomized Controlled Trial?
por: Scheper, Henk, et al.
Publicado: (2021)

Protein-based biofilm matrices in Staphylococci
por: Speziale, Pietro, et al.
Publicado: (2014)

Prosthetic joint infection due to Salmonellaspecies: a case series
por: Gupta, Arjun, et al.
Publicado: (2014)

Controversy about the Role of Rifampin in Biofilm Infections: Is It Justified?
por: Renz, Nora, et al.
Publicado: (2021)

1298. High Prescription Rate of Medications with Significant Rifampin Drug Interactions in Patients with Diabetic Foot Osteomyelitis: Should Rifabutin be Included in Clinical Trials for Adjunctive Therapy?
por: Mallarino-Haeger, Christina, et al.
Publicado: (2023)

Adjunctive Rifampin Following Debridement and Implant Retention for Staphylococcal Prosthetic Joint Infection: Is it Effective if not Combined With a Fluoroquinolone?
por: Cortés-Penfield, Nicolás W, et al.
Publicado: (2022)

Are late hernia mesh complications linked to Staphylococci biofilms?
por: Patiniott, P., et al.
Publicado: (2022)

Clinical and Microbiological Characteristics of Bacteroides Prosthetic Joint Infections
por: Shah, Neel, et al.
Publicado: (2017)

LASSBio-1586, an N-acylhydrazone derivative, attenuates nociceptive behavior and the inflammatory response in mice
por: Silva, Juliane Cabral, et al.
Publicado: (2018)

Rifabutin Is Active against Mycobacterium abscessus Complex
por: Aziz, Dinah Binte, et al.
Publicado: (2017)

Risk Factors for Fungal Prosthetic Joint Infection
por: Riaz, Talha, et al.
Publicado: (2020)

Rifabutin for the Treatment of Helicobacter pylori Infection: A Review
por: Gisbert, Javier P.
Publicado: (2020)

Prosthetic Shoulder Joint Infection by Cutibacterium acnes: Does Rifampin Improve Prognosis? A Retrospective, Multicenter, Observational Study
por: Vilchez, Helem H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3pbejj0f157a6uv1c12npsrtr0